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Abstract
A novel hypocrellin congener, 2-butylamino-2-demethoxy-hypocrellin B (2-BA-2-DMHB) was found to be an effective
photosensitizer. Compared with its parent compound hypocrellin B (HB), its absorption bands extended toward longer
wavelength and the extinction coefficients raised to some degree (Vmax (nm) (logA) : 463 (4.06), 583 (4.09), 621 (4.10) for 2-BA-
2-DMHB and 466 (4.06), 548 (3.70), 580 (3.52) for HB). And it also had a much higher photopotentiation factor than HB
(i.e., more than 250 versus 10 at a dose of 24 J cm32 of red light on HeLa cells). This might be correlated to the higher ability
of superoxide anion generation and the higher cellular uptake of 2-BA-2-DMHB. Meanwhile, the examinations of Hoechst
33342-labeled nuclei, DNA fragmentation on agarose gel and flow cytometry showed that 2-BA-2-DMHB induces apoptosis
in photosensitized HeLa cells more quickly than HB, which might be correlated to the higher cellular uptake of 2-BA-2-
DMHB and the difference of their cellular localization. The study suggested that 2-BA-2-DMHB was a well-suited candidate
for a new generation of photodynamic therapy photosensitizer. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Photodynamic therapy (PDT) consists of introduc-
ing a photoactive drug into the body and subsequent
illumination of tumor tissue by visible or near infra-
red light. In the presence of oxygen, illumination
activates the drug and in turn produces reactive oxy-
gen species leading to tissue damage. Owing to its
advantages such as its relative selectivity in most
sites, its compatibility with other treatment, its re-
peatability, its ease of delivery etc., PDT is slowly
¢nding its place as a useful cancer treatment for cer-
tain types of cancers or clinical situation, such as
early stage cancers of the lung, esophagus, stomach
cervix and cervical dysplasia, etc. [1].
To date, only Photofrin0 has been approved by
health boards in Canada, Japan, the Netherlands
and the United States [2]. In spite of the favorable
results obtained with Photofrin, some important fac-
tors still limit the e⁄cacy of PDT, including its com-
plex composition, the low extinction coe⁄cient in the
red spectral region and the prolonged cutaneous
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phototoxicity [3]. This is undoubtedly encouraging
the search for more ideally suited photosensitizers.
Hypocrellins, owing to their pure composition, fa-
vorable red light absorption spectra, high quantum
yields of singlet oxygen and facility for side-directed
chemical modi¢cation, have been selected as poten-
tial photosensitizers for PDT [4]. A lot of derivatives
of the parent hypocrellin B (HB) have been synthe-
sized and studied. Some of them have shown prom-
ising anticancer properties [5^11]. Here another novel
hypocrellin congener, 2-butylamino-2-demethoxy-hy-
pocrellin B (2-BA-2-DMHB) [12], is found to be an
e¡ective photosensitizer. Its phototoxicity to HeLa
cells and the initiation of apoptosis with it are re-
ported.
2. Materials and methods
2.1. Chemicals
Hypocrellin B (HB) was prepared by quantitative
potassium hydroxide dehydration of hypocrellin A
(HA) followed by neutralization with HCl, chloro-
form extraction, and recrystallization with benzene-
petroleum ether. 2-Butylamino-2-demethoxy-hypo-
crellin B (2-BA-2-DMHB) was prepared by re£ux
with n-butylamine in pyridine, neutralization, and
chloroform extraction of HB. The product was sub-
jected to 1% citric acid^silica gel thin-layer chroma-
tography (TLC), using a 6:1:1 mixture of petroleum
ether/ethyl acetate/ethanol (95%) as eluent, and three
compounds were obtained. They were the target
compound (rate of £ow (Rf ) = 0.64) and two by-
products (Rf = 0.74 and 0.40, respectively), which
were identi¢ed by satisfactory NMR, mass spectra
and elemental analysis [12]. The target compound
was further puri¢ed with TLC and the desired prod-
uct, 2-BA-2-DMHB, was obtained in 54% yield. The
purity of HB and 2-BA-2-DMHB was assessed by
high-performance liquid chromatography and found
to be higher than 95%. Their chemical structures and
absorption spectra are shown in Figs. 1 and 2, re-
spectively. Their absorption spectral parameters are
shown in Table 1. The photosensitizers were kept in
lyophilized form until the day of experiments, at
which time they were dissolved in DMSO.
5,5-Dimethyl-1-pyrroline-N-oxide (DMPO) and
9,10-diphenylanthracene (DPA) were purchased
from Aldrich Chemical Co., USA. Dulbecco’s modi-
¢ed minimum essential medium (DMEM), fetal bo-
vine serum (FBS), ethidium bromide (EB) and tris-
(hydroxymethyl) aminomethane (Tris) were purchased
from Gibco-BRL (Grand Island, NY, USA). Pro-
teinase K and sodium dodecyl sulfate (SDS) were
obtained from Merck (Rahway, NJ, USA). Agarose
was obtained from Promega (Madison, WI, USA).
RNase A, dimethyl sulfoxide (DMSO), 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) and propidium iodide (PI) were from
Sigma Chemical Co. (St. Louis, MO, USA). Hoechst
dye 33342 (HO342) was obtained from Molecular
Probes (Eugene, OR, USA). Other reagents are ana-
lytical grade.
2.2. Determination of reactive oxygen species yields
Singlet oxygen yields were determined as previ-
ously reported [4] by the DPA bleaching method.
The electron spin resonance (ESR) measurement
of spin trapping of DMPO was used to determine
the generation of Oc32 by hypocrellins [13].
2.3. Cell cultures
HeLa cells were maintained as monolayer culture
in DMEM containing 5% FBS and antibiotics PS (80
U/ml penicillin and 100 Wg/ml streptomycin) at 37‡C
in a humidi¢ed 5% CO2 incubator.
2.4. Distribution ratio
The distribution ratio of the photosensitizer is de-
¢ned as [Sen/g cells]/[Sen/ml medium]. The values
were measured as described previously [14]. Expo-
nentially growing cells were incubated in DMEM
with HB for 15 min or with 2-BA-2-DMHB for
6 h at 37‡C, ranging from 0 to 5 WM. Steady-state
Table 1
Absorption spectral parameters of photosensitizers in chloro-
form
Compound Vmax (nm) (logA)
HB 466 (4.06), 548 (3.70), 580 (3.52)
2-BA-2-DMHB 463 (4.06), 583 (4.09), 621 (4.10)
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intracellular levels were achieved at these times. The
cells were detached using 0.2% trypsin/0.5 mM
EDTA solution in phosphate-bu¡ered saline (PBS)
and centrifuge-washed to remove unbound dyes.
The washed pellets (2U106) were dispersed in 3 ml
of 10 mM Triton X-100 detergent. These solutions
were excited at 460 nm and the £uorescence emission
spectra were acquired using Hitachi-F4500 £uores-
cence spectrophotometer. Fluorescence at 610 nm
was determined, corrected for the £uorescence of
control (drug-free) samples and compared with a
standard £uorescence^intensity curve prepared with
HB and 2-BA-2-DMHB solutions of known concen-
tration.
2.5. Sensitizer localization
Cells growing on glass were incubated in DMEM
with 4 WM HB for 15 min or with 4 WM 2-BA-2-
DMHB for 6 h at 37‡C. Fluorescence was visualized
by Nikon FXA microscope to assess sites of sensi-
tizer location (excitation = 400^450 nm, emis-
sion = 600^650 nm).
2.6. Incubation and irradiation
Stock sensitizer^DMSO solutions were diluted
with DMEM containing 1% FBS. The ¢nal concen-
tration of DMSO did not exceed 1% (v/v). Exponen-
tially growing HeLa cells in 75-cm2 £asks (Costar,
Cambridge, MA, USA) were incubated with 2-BA-
2-DMHB in the dark for 6 h or HB in the dark for
15 min at 37‡C. The cells were detached using 0.2%
trypsin/0.5 mM EDTA solution in PBS and centri-
fuge-washed to remove unbound dyes. The cells were
then transferred to 35-mm dishes (Costar), 1 ml in
each dish containing 3U105 cells, and irradiated with
di¡erent doses of light. The light source was a Red
Light Treatment Instrument (Institute of Electronics,
Academia Sinica, China). Its total power output,
more than 90% at 600^700 nm, was 50 mW cm32
at the position of the samples, measured with a BTY-
8204 radiometer (Beijing Institute of Solar Energy,
China). Immediately after irradiation, 2 ml DMEM
containing 7.5% FBS was added to each dish. Then a
portion of the cells was assessed for survival as fol-
lows and the rest were incubated in the medium until
they could be checked for nucleus staining, DNA
fragmentation and £ow cytometry analysis.
Fig. 1. Chemical structures of HB and 2-BA-2-DMHB.
Fig. 2. The absorption spectra of HB (dashed line, 9.68U1035
M) and 2-BA-2-DMHB (solid line, 9.32U1035 M) dissolved in
chloroform.
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2.7. Cell survival studies
Cell survival was estimated by the MTT assay
[11,15,16]. PDT-treated cells were transferred into
£at-bottomed 96-well plates (Costar), 100 Wl in
each well containing 1U104 cells and the cells were
incubated at 37‡C in a CO2 incubator for 20 h. Via-
bility was determined by adding 10 Wl MTT (10 mg
ml31) to each well and the mixture was incubated for
4 h at 37‡C. Culture medium then was replaced with
dimethylsulfoxide to dissolve the formazan crystals.
The plates were shaken at room temperature for 10
min and read immediately at 595 nm on a Bio-Rad
model 3550 microplate reader (Richmond, CA,
USA). Samples were measured in 12 replicates and
each experiment was repeated at least twice. Survival
of PDT-treated cells was normalized against cells in-
cubated with photosensitizers alone.
The dark toxicity characteristic of each compound
was assessed separately following a similar procedure
for cell exposure to graded doses of HB for 15 min
or 2-BA-2-DMHB for 6 h. Precautions were taken to
avoid exposure of the cells to light throughout the
period when the cells were exposed to, or contained,
photosensitizers.
Photopotentiation is de¢ned as the molar concen-
tration ratio of the test compound required to
achieved an LD50 in vitro in the dark to that re-
quired to achieve an LD50 with 24 J cm32 of red
light, in a MTT assay [8].
2.8. Identi¢cation of apoptotic nuclei
Treated and control cells were incubated in
DMEM with 5% FBS for 24 h at 37‡C, then col-
lected by detachment and centrifugation and incu-
bated in growth medium (FBS free) containing
5 WM HO342 for 5 min at 37‡C. Nuclear fragmenta-
tion was assessed by £uorescence microscopy using
Nikon FXA microscope. The EX wavelength was
330^380 nm with EM monitored at 420^450 nm
[14]. Nuclei of both live and dead cells exhibit £uo-
rescence; apoptotic cells can be identi¢ed by the ap-
pearance of bright £uorescent regions of nuclear con-
densation or fragmentation [17].
2.9. DNA electrophoresis
The DNA was extracted as described previously
[18] with some modi¢cation. Cells (2U106) were de-
tached with the use of 0.2% trypsin/0.5 mM EDTA
solution, washed with PBS and pelleted by centrifu-
gation. The cell pellets were suspended in lysis bu¡er
consisting of 0.5% sodium dodecyl sulfate (SDS),
2 mM EDTA, 100 mg/ml proteinase K and 50 mM
Tris^HCl bu¡er, pH 8.0. After 24 h lysis at 37‡C,
Fig. 3. Localization of HB (left) and 2-BA-2-DMHB (right).
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the DNA was extracted with an equal volume of
water-saturated phenol/chloroform/isoamyl alcohol
(25:24:1). The aqueous phase was collected and
DNA was precipitated with 0.5 volume ammonium
acetate and 2.5 volumes cold absolute ethanol, and
stored overnight at 320‡C. The DNA was dissolved
in TE (0.5 M EDTA in 1 M Tris^HCl bu¡er, pH 8.0)
and incubated with DNase-free RNase A (100 mg/
ml) at 37‡C for 1 h. The samples were electrophores-
ed for 3 h at 60 V in 1.5% agarose gel containing 0.5
Wg ml31 ethidium bromide and visualized by UV
transillumination.
2.10. Flow cytometric detection of DNA
fragmentation
A propidium iodide (PI) staining technique was
used to assess the status of cellular DNA [19]. Cells
were washed twice with ice-cold PBS and then per-
meabilized and ¢xed in 80% ethanol at 4‡C for 24 h.
Cells were washed twice with PBS and suspended in
PBS with RNase A (100 mg/ml) and incubated at
37‡C for 30 min. At this point the PI solution (10
mg/ml in PBS) was added to the cells in RNase so-
lution, and the incubation was continued for 30 min
at 4‡C. After that, the cells were analyzed by Epics
XL £ow cytometer (Coulter, USA). Results are ex-
pressed as the percentage of cells exhibiting subdi-
ploid (6 2 N) amounts of DNA relative to the total
number of cells analyzed.
3. Results
3.1. Reactive oxygen species yields
The singlet oxygen yields of HB (0.76) and 2-BA-
2-DMHB (0.44) were determined by DPA bleaching
method, and shown in Table 2.
DMPO spin-trapping ESR measurement was used
here to verify the formation of superoxide anion rad-
ical generated by photosensitization of HB and
2-BA-2-DMHB. The results showed that the ability
of Oc32 generation by 2-BA-2-DMHB was higher
than that by HB (Table 2).
Fig. 4. Cytotoxicity (a) and phototoxicity (b,c, respectively) of
HB and 2-BA-2-DMHB.
Table 2
Quantum yields of photosensitizers in DMSO
Compound Quantum yields
(1O2)
Relative quantum yields
(Oc32 )
HB 0.76 1
2-BA-2-DMHB 0.44 2.7
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3.2. Distribution ratio and localization
We observed a distribution ratio of 49.1 þ 2.2 for
HB and 107.2 þ 4.3 for 2-BA-2-DMHB, using extra-
cellular drug concentrations that were varied between
0 and 5 WM. These results indicated that the intra-
cellular level of 2-BA-2-DMHB was approximately
two fold as much as HB when equimolar levels of
the drugs were used.
Fluorescence microscopy indicated that for HB,
prominent lysosomal uptake and endoplasmic retic-
ulum (ER) staining were evident, while the distribu-
tion of 2-BA-2-DMHB was primarily at ER (Fig. 3).
3.3. Photocytotoxicity and lethal dosage
The doses of photosensitizer that exerted 50% cy-
totoxicity, LD50, in the dark or light were estimated
from the survival curves for each photosensitizer.
Survival curves of the in vitro dark toxicity and
phototoxicity of HB and 2-BA-2-DMHB are shown
in Fig. 4. The LD50 of HB in the dark was about 20
WM and that of 2-BA-2-DMHB was more than 100
WM (Fig. 4a). That is to say, 2-BA-2-DMHB has
much lower cytotoxicity than HB.
Fig. 5. Fluorescence images of Hoechst 33342-stained HeLa cells. Cells were incubated in 4 WM 2-BA-2-DMHB for 6 h and irradiated
with LD70. (a) Untreated control cells ; (b) dark control cells (light dose = 0); (c) 24 h post-irradiation.
Fig. 6. The PDT-induced DNA fragmentation in HeLa cells :
lane 1, HB incubation alone (4 WM, 15 min); lanes 2 and 3, 24
h after HB photosensitization at LD70 and LD90, respectively;
lane 4, 2-BA-2-DMHB incubation alone (4 WM, 6 h); lanes 5
and 6, 24 h after 2-BA-2-DMHB photosensitization at LD70
and LD90, respectively; lane 7, marker (PUC^MspI digest).
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No cytotoxicity was induced upon exposure of
HeLa cells to red light alone (Fig. 4b,c) and the
corresponding MTT optical density was taken as
100% cell survival. In order to compare our results
with Estey’s results [8], we chose 24 J cm32 as the
testing dose. At this light dose, the LD50 of HB was
about 2 WM and its photopotentiation factor was 10,
which is equal to that of HB on EMT6 Ed mouse
tumor cells [8]. However, at this light dose, 2-BA-2-
DMHB caused 50% cytotoxicity at a concentration
within 0.25^0.5 WM (approx. 0.4 WM). Therefore
2-BA-2-DMHB was characterized by a more than
250-fold photopotentiation factor.
3.4. Hoechst 33342 nuclear staining
The morphology of dying cells was investigated
using the nuclear staining Hoechst 33342. In the ab-
sence light irradiation, the nuclei of 2-BA-2-DMHB-
treated HeLa cells remained intact, similar to those
of the normal cells (Fig. 5a,b). However, apoptotic
nuclei were detected in 2-BA-2-DMHB-photosensi-
tized cells (LD70) 24 h post-irradiation (Fig. 5c).
3.5. Gel electrophoresis
The fragmentation of DNA at the linker regions
Fig. 7. The DNA histogram of HeLa cells treated with PDT. (a) 2-BA-2-DMHB incubation only; (b) 24 h after 2-BA-2-DMHB pho-
tosensitization at LD90 ; (c) HB incubation only; (d) 24 h after HB photosensitization at LD90.
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between nucleosomes yielding fragments that are
multiples of 180^200 base pairs in size is a typical
hallmark of apoptosis. Agarose gel electrophoresis
was used to examine the production of apoptotic
DNA fragments. Fig. 6 shows the characteristic
DNA ladder observed in HeLa cells 24 h subsequent
to being treated with HB and 2-BA-2-DMHB at
LD70 and LD90, respectively (Fig. 6, lanes 2,3 and
lanes 5,6). No DNA ladder was observed when cells
were exposed to photosensitizers alone (Fig. 6, lanes
1 and 4). No obvious DNA ladder was detected at
3 and 6 h post-irradiation (data not shown).
3.6. Flow cytometric analysis
The cells treated with HB and 2-BA-2-DMHB
were analyzed by £ow cytometry. The results showed
the appearance of hypoploid cell population in pho-
tosensitized cells (Fig. 7). Percentages of apoptotic
HeLa increased along with incubation time post-ir-
radiation (Fig. 8). 2-BA-2-DMHB induced apoptosis
more quickly than HB. It was also found that an
obvious DNA ladder could be detected only when
the percentage of apoptotic HeLa was more than
20%.
4. Discussion
Hypocrellins cause many interests as photosensi-
tizers for PDT rests in their easily site-speci¢c modi-
¢ed basic structure and their ability to be synthesized
in pure, monomeric form. So a large number of de-
rivatives of HB have been synthesized and studied
[4^11]. In vitro screening studies have identi¢ed three
HB derivatives with desirable biological properties
and detailed preclinical analyses have been ¢nished
[10]. Now we have synthesized another new deriva-
tive of HB, 2-BA-2-DMHB. The compound had the
properties of an ideal photosensitizer, including
strong absorption of clinically used red light, low
dark cytotoxicity and excellent photopotentiation of
cellular damage.
First, light scattering in tissue is approximately in-
versely and exponentially proportional to wavelength
[20,21], so strong absorption in the red spectral re-
gion is useful for PDT of tumors. 2-BA-2-DMHB
exhibited strong absorption in the red spectral re-
gion. Compared with its parent compound HB, its
absorption bands extended toward longer wave-
lengths. The extinction coe⁄cient (A) at 583 nm
was 2.5-fold as much as HB at 548 nm, and at 621
nm was over 3.8-fold as much as HB at 580 nm
(Table 1). This will be more favorable to tissue pen-
etration of clinically used light.
Secondly, 2-BA-2-DMHB had excellent photopo-
tentiation of cellular damage. The MTT colorimetric
assay results showed that 2-BA-2-DMHB didn’t
evoke 50% lethality even at the highest concentration
tested (100 WM). This meant that the LD50 in the
dark of 2-BA-2-DMHB was more than 100 WM,
which is comparable to that of any HB derivatives
reported previously [8^10]. However, HB evoked
50% lethality at about 20 WM. In other words, the
cytotoxicity of 2-BA-2-DMHB was much lower than
that of HB. On the other hand, at a light dose of 24 J
cm32, the LD50 of 2-BA-2-DMHB was about 0.4
WM, while that of HB was 2 WM. So 2-BA-2-
DMHB showed over 25-fold photopotentiation as
much as HB in vitro, which would provide a wide
safety margin for drug administration.
Singlet oxygen is believed to be mainly responsible
for cell death induced by photodynamic action
[22,23]. However, it is interesting to note that the
singlet oxygen yield (Table 2) was not strongly cor-
related with photopotentiation in this study. While
the singlet oxygen yield of 2-BA-2-DMHB was more
than half of that of HB, the Oc32 yield of 2-BA-2-
DMHB was 2.7 times as great as that of HB. Oc32
might play an important role in cell death induced by
hypocrellins photosensitization. This problem needs
studying further. Furthermore, the intracellular level
Fig. 8. The percentages of apoptotic HeLa cells at di¡erent in-
cubation time post-irradiation (LD90).
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of 2-BA-2-DMHB was approximately two times as
much as that of HB when equimolar levels of the
drugs were used; this might be one of the reasons
why 2-BA-2-DMHB had more excellent photosensi-
tization than HB.
Thirdly, although PDT has been used for the treat-
ment of neoplastic diseases for over 20 years, the
mechanism of tumor cell destruction induced by pho-
tosensitizers was not fully understood. It was only 10
years ago that two main types of cell death were
identi¢ed, namely necrosis and apoptosis [24]. Apo-
ptotic responses have been observed in tumor cells
treated with various sensitizers such as AlPc (alumi-
num phthalocyanine) [15,24], PcD (porphycene
dimer) [25], hypocrellin A and its derivative [11].
Moreover, the ability to induce a rapid apoptotic
response is now believed to be important in the suc-
cessful treatment of cancer by PDT [25]. In this
study, we demonstrated that HB and 2-BA-2-
DMHB induced apoptosis in HeLa cells, as evi-
denced by Hoechst 33342 nuclear staining, agarose
gel electrophoresis and £ow cytometric detection of
DNA fragments (Figs. 5^7). The percentages of apo-
ptotic HeLa increased along with the incubation
time post-irradiation. The typical DNA ladder was
not obvious 3 and 6 h post-irradiation, but very clear
24 h post-irradiation, which suggested that DNA
fragmentation, was caused by an enzymatic process
rather than by direct photochemical damage to DNA
[11,26]. The study also showed that HB mainly lo-
calized at lysosomal and endoplasmic reticulum and
2-BA-2-DMHB mainly localized at endoplasmic re-
ticulum. Both endoplasmic reticulum and mitochon-
dria are Ca2 pools in cells [27]. The reactive oxygen
species in cells can damage the Ca2 transport sys-
tems located within ER and mitochondria, lead to a
disruption of intracellular Ca2 homeostasis, and
sustained Ca2 increases, resulting ultimately in apo-
ptosis [28]. Whether this type of mechanism partici-
pated in apoptosis induced by hypocrellins photosen-
sitization and whether they induced apoptosis via the
same pathway are being investigated. Besides, 2-BA-
2-DMHB induced apoptosis more quickly than HB,
which might be correlated to the greater uptake of 2-
BA-2-DMHB and the di¡erence in their cellular lo-
calization. Therefore, 2-BA-2-DMHB is probably an
e¡ective photosensitizer.
5. Conclusions
2-BA-2-DMHB had strong absorption in the red
spectral region, great uptake, very low dark cytotox-
icity and excellent photopotentiation of cellular dam-
age. Its phototoxicity to HeLa cells included apopto-
sis mode. Therefore, the new product is a well-suited
candidate for a new generation of PDT photosensi-
tizers.
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